{
  "pmcid": "6704347",
  "sha256": "57e74b309ad15fd61191b4a07659030a6fee12d278176a8cc0c5d19d6f603102",
  "timestamp_utc": "2025-11-09T22:51:44.378009+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.934538461538462,
    "reading_ease": 15.997961538461567,
    "word_count": 234
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Convection-Enhanced Delivery of Muscimol for Drug-Resistant Epilepsy"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In this phase 1 randomised controlled trial, 3 adult patients with DRE were recruited from a single center."
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included adults with confirmed DRE."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants underwent convection-enhanced delivery (CED) of artificial CSF vehicle followed by muscimol into the seizure focus for 12 to 24 hours using a crossover design."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was seizure frequency, assessed over the infusion period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was conducted using a computer-generated sequence, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not implemented."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Three patients were randomised, and all completed the study."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Three patients were randomised, and all completed the study."
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "Seizure frequency decreased in 1 of 3 patients during muscimol infusion but was unchanged during vehicle infusion."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]"
      }
    },
    "total_score": 14,
    "max_score": 25
  }
}